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Chapter




Sepsis is one of the most common reasons for hospitalisation. This condition is 
characterised by systemic inflammatory response to infection. International defini-
tion of sepsis mainly points out a multi-organ dysfunction caused by a deregulated 
host response to infection. An uncontrolled inflammatory response, often referred 
to as “cytokine storm”, leads to an increase in oxidative stress as a result of the inhi-
bition of cellular antioxidant systems. Oxidative stress, as well as pro-inflammatory 
cytokines, initiate vascular endothelial dysfunction and, in consequence, impair 
microcirculation. Microcirculation damage leads to adaptive modifications of cell 
metabolism. Moreover, mitochondrial dysfunction takes place which results in 
increased apoptosis and impaired autophagy. Non-coding RNA, especially miRNA 
and lncRNA molecules, may play an important role in the pathomechanism of 
sepsis. Altered expression of various ncRNAs in sepsis suggest, that these molecules 
can be used not only as diagnostics and prognostic markers but also as the target 
points in the pharmacotherapy of sepsis. The understanding of detailed molecular 
mechanisms leading to organ damage can contribute to the development of specific 
therapy methods thereby improving the prognosis of patients with sepsis.
Keywords: sepsis, cytokine storm, microcirculation, oxidative stress, RAS, ncRNA
1. Introduction
Sepsis was already known to ancient Greeks since the times of Hippocrates 
(460–370 BC) as a condition causing “rotting” of the body. Later, the Persian 
philosopher and physician Ibn Sina, or Avicenna (980–1037 AD) described for the 
first time sepsis as a “decay” of blood and tissues accompanied by fever. Sepsis is 
one of the most frequent causes of hospitalisation in Intensive Care Units. It consti-
tutes a significant clinical problem, in many cases with a fatal outcome. Significant 
advances in critical care medicine have defined sepsis as an organ dysfunction 
syndrome. The incidence of this type of disorder is still constantly rising. Morbidity 
significantly correlates with the ageing of societies and presence of other comor-
bidities. The prognosis is worse when the mentioned correlations are strong and the 
patient is diagnosed too late. Although sepsis can occur in any age group, its risk is 
definitely greater in patients over 60 years of age. Moreover, sepsis is growing rap-
idly as a result of a poorly controlled, multidirectional response of the organism to 
an external factor, i.e. pathogen, and its further increase may be due to endogenous 
factors or coexisting diseases [1].
Sepsis starts with a period of hyperinflammation, in which the macrophages, 
monocytes, T-cells and neutrophils are activated and recruited to various organs. 
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The uncontrolled inflammatory response, so-called cytokine storm leads to many 
metabolic disorders associated with oxidative stress. The oxidative stress, but also 
proinflammatory cytokines, promote endothelial function disorders and, conse-
quently, microcirculatory damages. At the final stage of cytokine storm a hypoin-
flammatory reaction develops, leading to multiple organ damages. These changes 
are underlined by mitochondrial function disorders, intensified oxidative stress and 
deregulation of apoptosis and autophagy processes. A neurohormonal activation, 
in the first place of the renin-angiotensin system (RAS), is an important element 
of the mechanisms leading to organ damage. Many studies have suggested that in 
sepsis, changes occur of the expression of various RNA molecules: long non-coding 
RNA (lncRNA) and microRNA (miRNA). The non-coding RNA fragments can 
thus play the role of molecular markers, both diagnostic, and prognostic, in the 
development of sepsis. The knowledge of the molecular mechanisms responsible for 
organ damages would enable a development of adequate and effective therapeutic 
methods, improving the prognosis for patients.
2. Cytokine storm in the course of sepsis
Cytokine storm is frequently described as an extremely dangerous immune 
response, being a positive feedback loop between cytokines and immune system 
cells [2]. That immune reaction provokes releasing of circulating proinflammatory 
cytokines, causing a direct threat to life. At the same time an increased activation 
occurs of the immune system cells as a result of, among other factors, action of 
various pathogens, autoimmune disorders, monogenic diseases or malignancies.
Proinflammatory cytokines, at the time of the beginning of the fight against 
pathogens by the immune system, send a signal to the lymphocytes and macro-
phages to start their transfer to the inflammation site. Cytokines activate also the 
cells to produce effector cytokines. All that cascade of interrelations frequently falls 
outside control, leading to hyperactivation of immune cells at a given site, damag-
ing the organ involved in the inflammation. Remote organs also suffer damages 
but in the mechanism of cytokine release into the circulation, activating other 
immune system cells. Moreover, according to the literature data, it is believed that 
some inflammation mediators can be helpful for the monitoring of the inflamma-
tory condition but also can be harmful for patient’s organism [2]. That depends on 
the patient’s health condition when the inflammation mediators are secreted into 
the bloodstream - whether the patient is in a physiological good condition or in a 
dysfunction state i.e. with upset immune system.
The course of cytokine storm itself can prognosticate the events being a con-
sequence of the inflammatory condition but also suggests possible effects after 
administration of an appropriate treatment. Cytokine storm includes a number of 
immune system disorders with characteristic systemic signs of inflammation and 
multiple organ dysfunction, leading to damage in case of inadequate therapy. A 
plethora of factors are directly or indirectly involved in cytokine storm. The key 
factors include: interferon γ, interleukin-1, −6, −18, TNF-α and NFκB, but the 
transcription factor NFκB emerges to the foreground in view of its ability to induce 
expression of proinflammatory genes. NFκB and its protein inhibitor (IκB) are 
located in the cell cytoplasm. NFκB activation can occur due to the effect of many 
stimulators, such as: bacterial pathogens recognised by Toll-like receptor 4 (TLR-4) 
or proinflammatory cytokines recognised by their specific membrane receptors 
(e.g. TNF receptor) [3].
The inhibitor protein closely related to NFκB, being a heterodimer built from 
two subunits: p50 and p65, undergoes phosphorylation. The phosphorylation 
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process is preceded by TLR-4 receptor activation by a lipopolysaccharide (LPS) 
complex with binding protein (LPS/LBP), leading to activation of redox-
dependent kinases. Then, after ubiquitination, a degradation of the inhibitor 
occurs in proteasomes, as shown in Figure 1. At the same time, the p50:p65 dimer 
is released from its bond with IκB and transferred to the cell nucleus, where it 
regulates the expression of the genes of the proinflammatory molecules: TNFα, 
IL-1β, IL-6, MCP-1 (monocytic chemoattractant protein 1). The NFκB factor can 
also activate the expression of inducible nitric oxide synthase (iNOS) and cyclo-
oxygenase-2 (COX-2). Such intensity of NFκB participation in immune system 
response, as well as in inflammatory reaction gives a possibility to consider that 
factor a candidate in the strategy of therapeutic management of multiple organ 
damage in sepsis [4].
3. Microcirculation and endothelial dysfunction in sepsis
Vascular endothelial cells constitute a dynamic vascular homeostasis regulator. 
They play not only the role of a barrier limiting the transportation of water, gases, 
proteins and cells between the intravascular and interstitial compartments, but also 
actively produce and release mediators, which regulate a wide range of physiological 
and pathological processes, including: vascular wall tension, angiogenesis, inflam-
matory condition and coagulation process. The activation and dysfunction of the 
endothelium are important elements of sepsis, and seem to play the key role in the 
sepsis phenotype as presented in Figure 2. During sepsis, endothelial cells become 
activated and dysfunctional, leading to haemostasis disturbances, increased migra-
tion of leucocytes, enhanced inflammatory condition, altered vascular wall tension 
and loss of the barrier function [5, 6]. The disturbed endothelial cell function can 
play a decisive role in microcirculation dysfunction. Microcirculatory changes in 
sepsis are characterised by heterogeneous perfusion of tissues due to absent or 
intermittent perfusion of the capillary vessels. Microcirculation heterogeneity in 
sepsis can disturb tissue oxygenation and lead to insufficient oxygen supply even in 
the presence of maintained total blood flow to organs. Such microcirculation dis-
orders create favourable conditions for perfusion impairment, insufficient oxygen 
supply to tissues and then for organ failure.
Figure 1. 
NFκB activation pathway.
Please use Adobe A robat Reader to read this book chapter for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is lo king documen loading.com
r
File cannot be found.
Infections and Sepsis Development
4
Figure 3. 
Change of endothelial cell properties after thrombin receptor stimulation.
Endothelial cells, receiving metabolic and physical signals regulate the microcir-
culatory flow through local releasing of vasodilating substances, particularly nitric 
oxide (NO), which modulate the tonus of vascular smooth muscles. NO is an activa-
tor of soluble guanylyl cyclase, the enzyme responsible for production of cGMP, a 
mediator of smooth muscle cell relaxation. For that reason, NO is considered the 
key factor of maintaining and autoregulation of homeostasis and microcirculation 
patency. During sepsis, the NO system is significantly disturbed – iNOS is non-
homogeneously expressed in various vascular spaces, what results in pathological 
blood flow in the microcirculation.
Endothelial cells usually promote antithrombotic properties and prevention of 
thrombocyte activation and aggregation. Endothelium also participates in the major 
pathogenetic pathways of diseases associated with a coagulopathy in sepsis, includ-
ing, in the first place, in tissue factor (TF)-mediated generation of thrombin, and in 
dysfunctional and impaired fibrinolysis. A natural antithrombotic protein – protein 
C is activated on endothelial cell surface, while thrombin binds to thrombomodulin 
(TM) – a transmembrane glycoprotein. In sepsis, the C protein system is weakened, 
possibly due to reduced synthesis and increased protein C consumption and reduced 
protein C activation as a consequence of reduced endothelial expression of throm-
bomodulin. In sepsis, an internalisation and degradation of TM occurs, leading 
to formation of inactive soluble fragments as illustrated in Figure 3. Under these 
Figure 2. 
Pathophysiology of microcirculatory change in sepsis.
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conditions the interaction between thrombin and thrombin receptor leads to a change 
of endothelial phenotype from antithrombotic to a prothrombotic phenotype.
In sepsis, the tissue factor can be released not only by monocytes and macro-
phages but also by endothelial cells. The TF pathway inhibitor, mainly expressed by 
endothelial cells, is functionally inhibited by reduced synthesis of glycosaminogly-
cans on endothelial surfaces. Furthermore, platelets, the aggregation of which leads 
to the development of thrombocytic thrombi, are a strong amplifier of the coagula-
tion cascade. Thrombus formation can be additionally facilitated by the factors 
released from neutrophils undergoing apoptosis. The formation of microvascular 
thrombi can cause tissue ischaemia and multiple organ failure.
4. Renin-angiotensin system in sepsis
The renin-angiotensin system (RAS) is one of the most important hormonal mecha-
nisms controlling haemodynamic stability through regulation of blood pressure, fluid 
volume and sodium-potassium balance as shown in Figure 4. Changes in the concentra-
tions of molecules which form RAS contribute to arterial hypertension development. 
Renin is synthesised in the kidneys as inactive form and released into the bloodstream, 
where pro-renin is proteolytically transformed into its active form. Active renin cataly-
ses angiotensinogen breakdown, generating angiotensin I (Ang I). Ang I is decomposed 
through angiotensin-converting enzyme (ACE) to angiotensin II (Ang II), the main 
effector in RAS (Figure 4). Ang I is also transformed through neutral endopeptidase 
(NEP) into angiotensin (1–7), another active peptide, which remains in opposition 
to Ang II (Figure 4). Angiotensin (1–7) can be also produced by Ang II splitting by 
angiotensin-converting enzyme 2 (ACE2), reducing thus Ang II concentration [7].
The mechanisms of RAS effect on sepsis development is presented in Figure 5. 
RAS participates in the pathogenesis of sepsis through equilibration of the modula-
tion of the inflammation-related pathways. Through binding to AT1R, Ang II can 
increase the abundance of inflammatory mediators, increase vascular permeability 
and stimulate the expression of chemoattractants and adhesive molecules and also 
lead to recruitment of inflammatory cells. Moreover, the activation of the ERK 
1/2, JNK, p38MAPK and NF-κB pathways is also involved in the intensification of 
inflammatory reaction by Ang II.
Figure 4. 
Renin-angiotensin system.
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Ang (1–7) can inhibit the activity of these signalling pathways and thus can 
inhibit the inflammatory reaction in sepsis. Many studies have provided evidence 
that RAS interventions can alleviate sepsis and associated organ function disorders 
through inhibition of the above mentioned inflammation-related pathways. ACE2 
exerts a protective effect against acute respiratory distress syndrome (ARDS) 
caused by sepsis, through inhibition of TLR4, ERK1/2, JNK and NF-κB pathways. 
Ang (1–7) inhibited the p38MAPK pathway in order to protect mice against sepsis-
induced skeletal muscle atrophy and liver damage. AT1R blockade can exert a 
protective effect against sepsis-induced multiple organ damage (SIMD) through 
inhibition of the MAPK and NF-κB pathways. Moreover, angiotensin I-converting 
enzyme inhibitors (ACEIs) and sartans (angiotensin receptor blockers, ARBs) 
decrease the release of proinflammatory cytokines, pro-oxidants and proapoptotic 
factors and thus alleviate the damages caused by sepsis.
5. Oxidative stress and mitochondria in sepsis
5.1 Generation of reactive oxygen species (ROS)
The internal mitochondrial membrane is a vast, impermeable structure contain-
ing enzymatic complexes of the respiratory chain (I – IV) and ATP synthase system 
(complex V). The transportation of electrons through respiratory chain complexes 
is accompanied by translocation of protons (H+) to the intermembrane space and 
development of potential difference on either side of the membrane.
That process includes development of reactive oxygen species (ROS) as a 
consequence of electron “escape” and mono-electron reduction of oxygen to 02. 
radical. That reaction occurs in the I and III complexes of the respiratory chain as 
presented in Figure 6. The developing oxygen free radicals are transferred both 
Figure 5. 
The mechanisms of RAS effect on sepsis development, blue line - promote; red line - inhibit.
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to the mitochondrial matrix and intermembrane space. The outer mitochondrial 
membrane is the site of location of NADPH, which generates hydrogen peroxide 
(H2O2). The ROS produced in the mitochondria cause damages of the mitochondrial 
proteins and mitochondrial DNA (mtDNA). These damages lead to the develop-
ment of a mega-channel, enabling outflow of cytochrome C into the cytosol, with 
consequent initiation of apoptosis process. An increased permeability of the inner 
mitochondrial membrane creates also a possibility of transportation of many small 
molecules. Mitochondrial ROS affects also many processes both under normal 
and pathological conditions, what as shown in Figure 7 can modulate vital cell 
functions.
5.2 Generation of reactive nitrogen species (RNS)
In sepsis, besides ROS production in the mitochondria, increased synthesis of 
nitric oxide (NO) is also an important element of oxidative stress. NO is produced 
by various cells, such as: activated macrophages, neutrophils or lymphocytes. 
Many molecules involved in septic inflammatory process, such as: tumour necrosis 
factor-α (TNFα) interferon γ (IFNγ) or interleukin-1β (IL-1β) also participate in 
the induction of type II NO synthase (iNOS) through activation of IκB degradation 
and transcription of iNOS gene.
An adequate nitric oxide production is a prerequisite of normal vascular struc-
ture and function. Muscle cells and haematopoietic cells are an important source of 
NO. Numerous inflammatory mediators participate in the induction and activation 
of the isoform of calcium-independent nitric oxygen synthase (iNOS). In order to 
prevent NO overproduction during sepsis, an administration of NOS inhibitors was 
suggested. NOS inhibition, however, has a limited therapeutic efficacy in view of 
intensification of organ dysfunction, which results in a high mortality rate. This is 
most likely related to the double role of iNOS in sepsis [8].
In particular cases, besides NO production, iNOS catalyses also the forma-
tion of reactive nitrogen species (RNS). NO reacts with superoxide anion to form 
peroxynitrite anion (ONOO−), which oxidises and nitrosylates various biological 
targets. Peroxynitrite can be a potential mediator of the cytotoxic effect of NO.
During sepsis, iNOS can become an important source of RNS as a consequence 
of enzyme decoupling. Decoupled iNOS is a source of superoxide anion, which 
is rapidly broken down by superoxide dismutase (SOD), and hydrogen peroxide 
(H2O2) is produced. Moreover, the availability of NO is reduced in view of its rapid 
reaction with the peroxide. During sepsis, three main factors can contribute to 
iNOS decoupling: suboptimal tetrahydrobiopterin (BH4) concentration, insufficient 
Figure 6. 
ROS production in mitochondria.
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concentration of L-arginine substrate and also increased production of asymmetric 
dimethylarginine (ADMA, endogenous NOS inhibitor) [8].
5.3 Cellular antioxidant systems
Cells have developed protective mechanisms counteracting mitochondrial 
dysfunction. The most important of them include: a system of endogenous anti-
oxidants, dynamic changes of mitochondria and also processes of removal of 
damaged organelles and biogenesis of new ones. To counteract oxidative damage, 
mitochondria contain high concentrations of antioxidants, i.e. substances, which, 
when present in low concentrations, reduce the level and/or protect the substrates 
against their oxidative modification. ROS uptake is the function of the antioxidants. 
Two types of antioxidants can be distinguished: enzymatic and non-enzymatic. The 
important antioxidant enzymes include superoxide dismutase (SOD), catalase and 
glutathione peroxidise (GPx). SOD catalyses conversion of O2
. to H2O2 and oxygen. 
In mammalian cells two forms of SOD are present: CuZnSOD (SOD 1) and MnSOD 
(SOD 2). SOD 1 requires presence of copper and zinc as cofactors and is mainly 
present in cytosol, while SOD 2 is manganese-dependent and is mainly found in 
mitochondria. The hydrogen peroxide produced as a result of a reaction catalysed 
by SOD is then detoxicated by catalase or GPx. In the reaction catalysed by cata-
lase, water and oxygen are produced. GPx converts H2O2 into water in a reaction, 
in which glutathione (GSH) is oxidised to glutathione disulfide (GSSG) and then 
reduced to GSH by glutathione reductase (GR). Both GPx and GR require the pres-
ence of selenium to reach their full activity.
The important non-enzymatic antioxidants include vitamins, enzymatic cofac-
tors and many endogenous substances. The antioxidant vitamins include vitamin 
A, C and E, which mainly act as compounds scavenging free radicals. As mentioned 
above, microelements such as manganese, copper, zinc, and selenium are important 
elements of the antioxidant systems. Endogenous antioxidant substances include in 
the first place bilirubin albumin, ferritin and melatonin.
5.4 Mitochondrial dynamics
Mitochondria are dynamic organelles undergoing constant regular cycles of 
fusion and breakdown. The fusion of damaged mitochondria and then asymmetric 
breakdown are the mechanism leading to regaining of the functionality of the basic 
Figure 7. 
The role of ROS in normal and pathological conditions.
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components. The damaged elements present in the organelles can be grouped, as a 
result of fusion, in one mitochondrium. Asymmetric breakdown leads to creation 
of functionally efficient organelles and of mitochondria, in which all damages are 
accumulated. These dysfunctional mitochondria are eliminated by autophagy [9].
Mitochondrial fusion and breakdown are strictly balanced processes. Both an 
uncontrolled fusion and breakdown can constitute an extreme threat to the cell 
function and lead to cell death. At present, the data on mitochondrial fusion and 
breakdown in critical conditions are scarce. An increased level of markers present-
ing the mitochondrial dynamics was found in post mortem liver biopsies but not in 
vivo in critically ill patients. In an animal model, in rabbits, which had a significant 
dysfunction of the hepatic and renal mitochondria, the level of mitochondrial 
fusion protein of the inner membrane (optic atrophy protein-1) was only signifi-
cantly increased in the liver. A reduction was also observed of the concentration 
of mitofusin-2, involved in the fusion of the outer mitochondrial membrane. The 
breakdown markers remained unchanged in both organs. The results of those stud-
ies may suggest that the ability of the mitochondria to fuse and break down differs 
between the organs.
The elimination of dysfunctional mitochondria requires replenishing of their 
population through biogenesis. Mitochondrial biogenesis depends on nuclear and 
mitochondrial transcription systems. Peroxisome proliferator-activated recep-
tor gamma-activator 1 alpha (PGC-1α) has been identified as the key element of 
the biogenesis process. It activates the nuclear respiratory factors 1 and 2 (NRF1, 
NRF2), which induce important transcription factors, such as mitochondrial tran-
scription factor A (TFAM) and nuclear-encoded mitochondrial proteins – subunits 
of respiratory chain complexes. That complex transcription programme causes 
mtDNA replication and synthesis of new proteins indispensable for development of 
new mitochondria. That programme is extremely metabolically expensive, since it 
requires a huge energy expenditure.
In animal sepsis models increased levels were observed of hepatic markers of 
mitochondrial biogenesis: PGC-1α, NRF1 and TRAM, which was associated with 
regaining of metabolic activity and improvement of the clinical condition. No 
differences were found in the levels of hepatic and renal mitochondrial biogenesis 
markers in rabbits, which were in critical condition but survived, compared to the 
animals, which failed to survive the experiment. In patients surviving a sepsis, no 
changes in mitochondrial protein synthesis were observed in vivo, in spite of an 
increase of the mRNA level of mitochondrial transcription factors.
6. Apoptosis in sepsis
Apoptosis plays a significant role in the pathophysiology of sepsis. The role of a 
potential factor involved in immunosuppression and mortality in sepsis has been 
ascribed to lymphocyte apoptosis. An increased apoptosis of T and B cells was 
observed in patients dying of sepsis. The results of clinical studies have confirmed 
the observations, which demonstrated a significant increase of lymphocyte apop-
tosis in the model of cecal ligation and puncture (CLP)-induced sepsis in mice. 
Although death of adaptative immune system cells, limiting thus the inflammatory 
reaction, may be beneficial for the body, but the presence of intense apoptosis of 
immune cells leads to a reduced possibility of defence during invasion of pathogens. 
It seems that lymphocyte apoptosis, leading to immune response impairment, can 
predispose to septic death. That suggestion has been confirmed by the results of 
studies in transgenic mice with increased expression of antiapoptotic Bcl-2 pro-
tein. In the model of CLP-induced sepsis a protective effect of Bcl-2 on T-cells has 
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been demonstrated, which increased the survival. That suggests that apoptosis of 
immune cells plays a significant role in the development of sepsis and is of decisive 
importance for its possible unfavourable course. The role of a apoptosis of various 
cells in sepsis and its consequences for organ function is presented in Figure 8.
In experimental sepsis models, also an intense apoptosis has been observed of 
interstitial cells, such as intestinal and pulmonary epithelial cells. A defect of intes-
tinal epithelial cells can lead to a significant impairment of their barrier function 
and to facilitation of bacterial translocation into blood and/or lymphatic system. 
That results in an increased antigen presentation and massive immune response, 
which have a direct effect on the survival.
Apoptosis of pulmonary epithelial cells leads to the development of acute lung 
injury (ALI). That pathology is directly caused not only by inflammation or trauma 
but also by haemorrhagic shock and multibacterial sepsis. The silencing of Fas 
receptors on the membranes of pulmonary epithelial cells in mice with haemor-
rhagic shock, leads to ALI reduction through blocking of their apoptosis and, thus, 
inhibition of histological remodelling of the lungs.
7. mTOR and autophagy in sepsis
The mTOR pathway plays an important role in promoting sepsis progression. 
TLR4 activation through LPS binding increases mTOR activity. In a clinical study 
in 106 patients with sepsis an activation of HIF-1α and mTOR genes was observed 
in peripheral blood leucocytes. An injection of LPS to mice caused an activation 
of mTOR signalling in macrophages and led to an increase of inflammatory renal 
injury followed by fibrosis. An activation of mTOR pathway by LPS in rats resulted 
in a blood pressure reduction and heart rate acceleration and also in an increase of 
the level of inflammatory markers in the tissues of the kidneys, heart and blood 
vessels. In both mentioned animal models, an administration of rapamycin and 
mTOR inhibitor significantly reversed the harmful effects of LPS. The inhibition of 
mTOR in sepsis can be partly explained by activation of the autophagy process.
Autophagy is a degradation system, preserved in an evolutionary way in the 
cells, and it participates in maintaining of intracellular homeostasis. The process of 
autophagy includes formation of autophagosomes, fusion of autophagosome-lyso-
somes and development of degradation products. In sepsis, autophagy is a recog-
nised protective adaptative mechanism limiting cell injury and apoptosis [10, 11]. 
Autophagy not only eliminates damaged protein aggregates and organelles, but also 
Figure 8. 
Apoptosis of various cells in sepsis and its consequences for organ function.
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eliminates bacteria and pathogens present in the cytoplasm. Some special bacteria, 
such as Staphylococcus aureus, can avoid selective autophagy through activation of 
cell kinases of the host.
The main role of autophagy in sepsis illustrates in Figure 9. Autophagy promotes 
pathogen elimination directly by phagocytosis, regulation of antigen presentation, 
activation of immune cells and secretion of type I interferon. It inhibits the immune 
response through degradation of inflammasomes. It prevents immunosuppres-
sion through inhibition of apoptosis and elimination of damaged mitochondria. 
It affects the metabolism through regulation of mitochondrial functions and 
participation of AMPK and mTOR in the regulation of autophagy activity. That 
effect is, however, limited. In the case of severe sepsis, even a significant increase 
of autophagy fails to reverse the overwhelming inflammatory reaction. The body of 
evidence gathered, suggest that autophagy dynamically changes to become insuf-
ficient and non-adaptative at later stages of sepsis. Dynamic changes of autophagy 
during sepsis was shown in Figure 10. That deficit is associated with mTOR signal-
ling regulation, while ineffectiveness of elimination of dysfunctional organelles 
and toxic intracellular material causes an overwhelming accumulation of danger-
associated molecular patterns (DAMPs).
Both autophagy and mTOR pathway are promoted at the initial stages of sepsis. 
At later sepsis stages a long-lasting drop of autophagy is observed, contributing to 
organ dysfunction and reduced lymphocyte count, what is important for inflam-
matory dysregulation, apoptosis and mitochondrial disorders. Two separate animal 
models demonstrated that autophagy regulation through rapamycin administration 
reversed the heart damage observed during sepsis. These studies have shown that 
mTOR is the main inhibitor of autophagy.
Autophagy has been proposed as a potential therapeutic goal, particularly 
during evident immunosuppression and then in the phase of sepsis, as a way of 
immune homeostasis restoration. It seems that autophagy promotion can be a novel 
Figure 9. 
The main role of autophagy in sepsis.
Figure 10. 
Dynamic changes of autophagy during sepsis.
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and effective intervention in order to reduce organ dysfunction caused by insuf-
ficient and non-adaptative autophagy during severe sepsis.
8. Non-coding RNAs in sepsis
Non-coding RNAs are responsible for the regulation of many cell signalling 
pathways. The molecules include long non-coding RNA (lncRNA) and microRNA 
(miRNA), participating in many biological processes, such as apoptosis, mitochon-
drial dysfunction and innate immunity.
All cells synthesise RNA molecules of 21 to 25 nucleotide length, called miRNA. 
The molecules of miRNA bind to complementary sequences at 3′ ends of target 
mRNAs and are able to post-transcriptionally regulate the expression of many 
genes. They can, therefore, exert protective or harmful effects in various immune 
system-related disorders and affect the levels of proinflammatory cytokines: TNFα 
and IL-1β through signalling pathways including p38 mitogen-activated protein 
kinase (MAPK) and MAPK 1 phosphatase (MKP-1). Many studies have demon-
strated significant differences in the expression of some miRNAs in septic patients. 
It was suggested, therefore, that miRNAs may serve as biomarkers in the diagnostic 
process or risk stratification, and even can be a therapeutic target in the treatment 
of sepsis.
The lncRNA family includes molecules of protein-non-coding RNAs contain-
ing about 200 nucleotides and consists of over 60,000 individually catalogued 
members. lncRNAs have many functions and activities such as: regulation of gene 
expression, changing chromatin arrangement, modification of histones and alter-
native gene splicing, which suggest their possible role in the pathogenesis of various 
diseases and disorders.
8.1 MicroRNA
MicroRNA molecules play an important role in the regulation of adaptative and 
innate immune responses in the pathogenesis of sepsis as presented in Table 1. The 
molecules affect the development of regulatory T-cells and also T-helper cells, which 
are indispensable for immune response optimisation. During sepsis the immune 
system of the host seems to be both in the state of immunosuppression, but also, at 
the same time can be in a proinflammatory state [12].
In proinflammatory state, many cytokines, including TNFα, are overexpressed. 
miRNAs can control TNFα production both at translation and transcription levels. 
miR-181 has been shown to regulate TNFα synthesis through intensification of 
TNFα mRNA degradation. It has been also observed that a significantly reduced 
miR-125b expression was accompanied by a higher TNFα expression in the mono-
cytes of newborns after LPS stimulation. Besides that, miRNAs can also regulate 
the TNF pathway and mediate inflammatory reactions. It has been suggested that 
miR-511 is a regulator of TNF receptor protein synthesis and, thus, it affects the 
sensitivity of cells to TNF. An effect of miR-511 is therefore possible, protecting 
against TNF-dependent endotoxic shock syndrome. It has been also demonstrated 
that the levels of other proinflammatory cytokines, such as IL-6, are significantly 
increased in septic patients. Experimental studies have shown that miR-146a 
expression is correlated with an increased IL-6 concentration in septic patients. 
Many studies have demonstrated that miRNA molecules are able to regulate 
inflammatory reactions through their effect on the Toll-like receptor 4 (TLR4) 
signalling pathway. The TLR4-induced signalling activates in the first place NFκB, 
the key transcription factor modulating the expression of proinflammatory and 
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immunoregulatory factors. Some miRNA molecules, such as miR-155, miR-125 and 
miR-146a play the main role in the negative modulation of the TLR4/NFκB inflam-
matory cascade, but also in innate immunity. The expression of miR-155 and also 
many other miRNA molecules depends on NFκB, since it has been shown that LPS 
stimulation of THP-1 monocytes induces the expression of miR-146a and miR146b. 
The miR146a molecule directly regulates the expression of TNF receptor-associated 
factor 6 (TRAF6) and IL-1 receptor-associated kinase 1 (IRAK1), which are 
important adaptor molecules in the TLR4 signalling pathway. miR-146a plays also 
a significant role in the in vitro tolerance of monocytes to endotoxins. That effect 
can be, however, reversed by miR-146a suppression. It has been recently reported 
that the NFκB/DICER signalling pathway inhibits TNFα synthesis through produc-
tion of mature forms of miR-130 and miR-125b, which regulate TNFα mRNA. The 
presented miRNA effects seem particularly important in the aspect of the critical 
role of TLR4-induced pathway in sepsis.
8.2 lncRNAs and sepsis
The molecules of lncRNA play an important role in biological processes and 
their dysregulation is associated with various disorders [13]. The experimental 
studies presented in Table 2, were conducted in order to assess the correlation 
between sepsis and expression of lncRNA molecules. It has been demonstrated that 
lncRNA expression is changed in human monocytes, cardiomyocytes and renal 
canalicular epithelial cells during development of sepsis or after exposure to LPS.
miRNAs Expression 
in Sepsis
Observed effects of miRNAs
miR-150 down miR-150 levels in both leukocytes and plasma correlated with the severity 
of sepsis and could be used as a marker of early sepsis. Plasma ratio of 
levels of miR-150/IL-18 could be used for assessing the severity of sepsis
miR-31 down miR-31 down regulation in CD4+ T cells contributes to 
immunosuppression in sepsis patients via promoting TH2 skewing 
humans T cells
miR-27a down miR-34a, miR-15a, and miR-27a are correlated with shock development in 
severe sepsis patients; they also target cell cycle regulation, apoptosis, cell 
layer permeability, and inflammatory pathways humans plasma
miR-25 down A correlation between levels of miR-25 and the severity of sepsis 
was observed; surviving patients had higher levels of this biomarker 
compared with non-surviving subjects; decreased levels of miR-25 were 
associated with the concentrations of oxidative stress indicators in sepsis
miR-15a up Upregulated miR-15a down regulated the LPS induced inflammatory 
pathway
miR-16 up Upregulated miR-16 down regulated the LPS induced inflammatory 
pathway
miR-574-5p up Serum level was correlated with the death of sepsis patients; the 
combined analysis of miR-574-5p, SOFA humans serum scores, and the 
sepsis stage on the day of diagnosis provided a good predictor for sepsis 
prognosis
miR-297 up serum miR-297 level was higher in survivors than non-survivors among 
septic patients
miR-143 up serum miR-143 levels were significantly higher in sepsis than in SIRS and 
healthy controls
Table 1. 
Selected miRNAs involved in human sepsis.
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In spite of many studies on that topic, sepsis still remains a complex clinical 
condition, the pathophysiology of which has not been fully elucidated. Non-coding 
RNAs offer a chance for early diagnosis and monitoring of patients in Intensive 
Care Units.
9. Conclusions and perspectives
Uncontrolled inflammation, immune disorders, oxidative stress, apoptosis, 
mitochondrial damage and also endothelial function disorders play the key role in 
sepsis and organ dysfunction associated with it. Sepsis releases a series of signalling 
cascades, starting with recognition of the whole spectrum of pathogen-associated 
molecular patterns (PAMPs) and organ damage-associated molecular patterns 
(DAMPs). Each stage of the signalling pathways participating in the release of 
inflammatory mediators is extremely important for the course of the disease and 
can be a target point in the therapeutic strategy in septic patients. The general 
agreement present as yet, concerning the inflammatory response only mediated 
by the TLR4/NFκB pathway is not so obvious any longer. Administration of anti-
inflammatory drugs, including corticosteroids, or antagonists of TNFα and IL-1, 
failed to produce the expected effects in septic patients.
The target points in the treatment of sepsis can also be the molecules of non-
coding RNA (ncRNA). Recent studies have suggested, among other findings, that 
the miRNA-23b molecule prevents the development of myocardial dysfunction in 
late sepsis. It seems therefore, that research in the field of development of drugs 
targeted at ncRNA molecules can be the future of antiseptic pharmacotherapy.
The new SARS-CoV-2 coronaviral disease has aroused interest in viral sepsis. 
Although bacteria are the predominant pathogens in sepsis, a viral sepsis cannot be 
disregarded. According to the literature reports, the percentage of septic patients 
with negative results of blood cultures for bacterial pathogens reaches 42% [14, 15]. 
In COVID-19 patients a septic shock and multiple organ dysfunction may develop. 
In view of absence of specific drugs, the current therapeutic strategies include 
isolation of patients, controlling of infections and maintaining normal organ 
lncRNAs Expression 
in Sepsis
Observed effects of lncRNAs
NEAT1 up Circulating lncRNA NEAT1 was related to severity, increased risk, 
and unfavourable prognosis in sepsis patients
ANRIL/miR-
125a axis
up lnc-ANRIL/miR-125a axis could serve as a biomarker for prognosis, 
severity, and inflammation in sepsis patients
ITSN1-2 up High expression of ITSN1-2 is associated with disease severity and 
inflammation in sepsis patients.
TUG1 down Decreased TUG1 expression may induce sepsis related AKI by 
modulating the NF-kB pathway and regulating the miR-142-3p/
SIRT1 axis (humans in vitro)
MALAT1 down IL-6 induced upregulation of MALAT1 in LPS treated 
cardiomyocytes, and MALAT1 could promote the expression of 
TNF-a at least partly bySAA3 in response to LPS treatment in 
cardiomyocytes (mice in vitro)
HULC down Upregulation of lncRNA HULC is required for the pro-inflammatory 
response during LPS induced sepsis (mice in vitro)
Table 2. 
Selected lncRNAs involved in sepsis.
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functioning. The SARS-CoV-2 infection depends on the host’s cell factors. Recent 
studies have demonstrated that COVID-19 virus uses the angiotensin 2-converting 
enzyme (ACE2) and serine protease TMPRSS2 to penetrate into host’s cells. That 
suggests a possibility of administration of protease inhibitors as effective drugs 
blocking the transmission of the virus [16]. The studies on viral sepsis caused by 
COVID-19 could help to indicate also other target points for drugs, which would 
reduce the damages of the lungs and other organs.
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